UK researchers have demonstrated that gene therapy can significantly improve vision in young children with retinal dystrophy caused by genetic deficiency of AIPL1.1

ODMAFair25, from 27-29 June in Sydney, will present a series of educational sessions and hands-on workshops designed to arm delegates with new knowledge and

Australia’s Seonix Bio has announced the launch in the United States of SightScore, the first commercially available clinical polygenic risk score testing service for

Macular Disease Foundation Australia (MDFA) is calling on the government to extend bulk billing to Australian pension card holders who require eye injections for